Addus HomeCare (ADUS) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
23 Apr, 2026Company overview and business model
Operates 262 locations in 23 states, serving about 62,500 consumers with 50,000 employees.
Focuses on personal care, hospice, and home health services, primarily for elderly, chronically ill, or disabled individuals.
Personal care is the largest segment, accounting for 76.5% of 2025 net revenues.
Provides cost-effective, long-term care that helps consumers avoid more expensive institutional settings.
Mission centers on enabling people to remain in their homes through affordable care and assistance.
Financial performance and stability
2025 revenues reached $1.4 billion, with adjusted EBITDA of $180 million and a CAGR of 14.4% (revenue) and 21.0% (EBITDA) from 2022-2025.
Gross margins have remained stable at 32.5% in 2025, with adjusted EBITDA margin rising to 12.7%.
Net income per diluted share grew from $2.84 in 2022 to $5.22 in 2025, with adjusted net income per share at $6.23.
Minimal capex requirements (0.5% of revenue in 2025) and strong free cash flow conversion.
Maintains a strong balance sheet with $81.6 million in cash, $121 million in bank debt, and $517.7 million available on a $650 million revolving credit facility.
Growth strategies and acquisitions
Pursues organic growth through increased referral source interaction, sales force enhancement, and technology investments.
Executes a disciplined acquisition strategy, focusing on accretive deals in existing and adjacent markets.
Recent acquisitions include Gentiva's personal care operations ($350M), expanding coverage in seven states and entering Texas.
Acquisitions are immediately accretive to earnings and broaden service offerings and geographic reach.
Value-based care opportunities are enhanced by offering multiple service segments in key geographies.
Latest events from Addus HomeCare
- Virtual annual meeting to vote on directors, auditor, and executive pay, with strong governance focus.ADUS
Proxy filing23 Apr 2026 - Hospice recovery, census growth, and tech-driven hiring fuel expansion amid stable rates.ADUS
2026 KeyBanc Capital Markets Healthcare Forum17 Mar 2026 - Strong Q4 exit, tech-driven efficiency, and robust growth outlook amid regulatory changes.ADUS
Oppenheimer 36th Annual Healthcare MedTech & Services Conference16 Mar 2026 - Margins, growth, and M&A drive performance as census rebounds and tech boosts fill rates.ADUS
47th Annual Raymond James Institutional Investor Conference3 Mar 2026 - Q4 2025 revenue and EBITDA surged, led by personal care and hospice growth.ADUS
Q4 202524 Feb 2026 - Growth driven by acquisitions, tech, and value-based care, with census recovery expected by 2026.ADUS
Jefferies 2025 Healthcare Services Conference3 Feb 2026 - Q2 revenue up 10.4%, net income $18.1M, major equity raise, Gentiva deal, NY divestiture.ADUS
Q2 20242 Feb 2026 - Strong growth, strategic market exits, and value-based care drive expansion and resilience.ADUS
Jefferies 2024 Global Healthcare Conference1 Feb 2026 - Q3 revenue up 7%, EPS up 13%, with Gentiva deal and NY exit to drive future growth.ADUS
Q3 202416 Jan 2026